Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

ARDELYX, INC. — Lobbying — Receipts Report

LD-2 disclosure · 3rd Quarter - Report (No Activity)

ARDELYX, INC.

via ARDELYX, INC.

3rd Quarter (July 1 - Sep 30) · 2022Posted Jan 5, 2023Filing document ↗LDA record ↗

Expenses$130Kself-filed spend

Client

Name: ARDELYX, INC.
Location: Massachusetts · United States of America

Registrant

Firm: ARDELYX, INC.
Description: Biopharmaceutical company
Location: Freemont, California, United States of America

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.